Quantcast

Latest cardiovascular disease Stories

2014-09-10 16:26:00

WOODBRIDGE, ON, Sept. 10, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today the publication of results of a prospective randomized controlled trial in the U.S. that evaluated the effects of VASCAZEN(®) in the correction of Omega-3 deficiency in patients with one or more risk factors associated...

2014-09-10 08:32:05

Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease MARLBOROUGH, Mass., Sept. 10, 2014 /PRNewswire/ -- Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for life and to developing innovative therapies in interventional cardiology. The company will share results from more than a dozen clinical studies at the 26th Transcatheter...

2014-09-09 23:15:05

A man’s likelihood of accumulating fat around his heart – an important indicator of heart disease risk – may be better determined if doctors consider his race and ethnicity, as well as where on his body he’s building up excess fat, reveals an international evaluation led by the University of Pittsburgh Graduate School of Public Health. Pittsburgh, PA (PRWEB) September 09, 2014 A man’s likelihood of accumulating fat around his heart – an important indicator of heart disease...

2014-09-09 23:12:35

According to Neuropsychologist Dr. Kenneth Freundlich with Morris Psychological Group one side effect that is just beginning to be understood is that heart disease has consequences for thinking and communication. Parsippany, NJ (PRWEB) September 09, 2014 As medical intervention and treatment have improved and as people have become more conscientious about lifestyle factors that improve heart health, deaths from heart disease have declined. According to the American Heart Association,...

2014-09-09 23:03:04

Soulati Will Address How to Prevent and Reverse Cardiovascular Disease with Her Lifestyle Modification Program, the Sara Soulati Health for Life Program, Combined with Enhanced External Counterpulsation (EECP) Los Angeles, CA (PRWEB) September 09, 2014 Sara Soulati, CEO and Founder of Global Cardio Care, is presenting a lecture to seniors at Crenshaw Christian Center in Los Angeles at 10 a.m. on Sept. 11, 2014. A clinical team will attend and offer advice on regular screenings to monitor...

2014-09-08 12:29:37

WOODBRIDGE, ON, Sept. 8, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, today announced the appointment of Prakash Gowd as the Company's Chief Financial Officer. Mr. Gowd succeeds Eugene Bortoluzzi, who will remain Pivotal's Chief Executive Officer. In addition to having an impressive track record as one...

2014-09-07 11:59:54

Heart disease is an umbrella term for a wide range of related conditions that affect the heart. Coronary heart disease is one example, resulting from plaque build-up on the inner walls of arteries – this reduces the blood flow to the heart and thereby increases the chances of experiencing a heart attack or other complication. Other common heart conditions include: Brugada Syndrome This is a condition that affects the heart rhythm by restricting the sodium ions in heart cells,...

2014-09-03 16:29:13

WOODBRIDGE, ON, Sept. 3, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today that the cardio-protective effects of Pivotal's unique Omega-3 formulation commercialized as VASCAZEN(®) was presented at the 2014 Annual Scientific Meeting of the European Society of Cardiology ("ESC") Congress 2014 in...

One Hour Of Moderate Exercise A Day Could Decrease Risk Of Heart Failure
2014-09-03 03:21:10

American Heart Association In a new study reported in the American Heart Association journal Circulation: Heart Failure, researchers say more than an hour of moderate or half an hour of vigorous exercise per day may lower your risk of heart failure by 46 percent. Heart failure is a common, disabling disease that accounts for about 2 percent of total healthcare costs in industrialized countries. Risk of death within five years of diagnosis is 30 percent to 50 percent, researchers said....

2014-09-02 23:04:30

Study by Thomson Reuters reveals most impactful global scientific researchers Kansas City, Mo (PRWEB) September 02, 2014 David J. Cohen, M.D., M.Sc., and John A. Spertus, M.D., M.P.H., cardiologists with Saint Luke’s Mid America Heart Institute in Kansas City and the University of Missouri – Kansas City, have dedicated their professional lives to cardiovascular research, producing innovative and impactful science that has defined and shaped cardiovascular care across the country. In...


Latest cardiovascular disease Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related